Inclusive of all taxes
AZITHRO-MAX 250 Tablet by Dr Precision is a highly effective and clinically trusted antibiotic containing 250 mg of Azithromycin, a macrolide antimicrobial agent. This formulation is specifically designed to combat a broad spectrum of bacterial infections including respiratory tract infections like community-acquired pneumonia, sinusitis, pharyngitis, and tonsillitis; dermatological infections such as cellulitis, impetigo, folliculitis, and infected wounds; as well as urogenital infections including non-gonococcal urethritis and cervicitis caused by Chlamydia trachomatis. Manufactured under stringent GMP-compliant standards, AZITHRO-MAX 250 provides optimal bioavailability with rapid gastrointestinal absorption and peak plasma levels within 2-3 hours. Its superior pharmacokinetic profile enables extensive tissue distribution and intracellular accumulation within phagocytic cells, delivering targeted and prolonged antibacterial activity at infection sites. This supports convenient once-daily dosing and shorter treatment durations, typically 3 to 5 days, improving patient adherence in both outpatient and pediatric use. The long terminal half-life of approximately 68 hours contributes to sustained antibacterial effects and a notable post-antibiotic action. AZITHRO-MAX 250 is thus an essential therapeutic option for healthcare professionals seeking an efficient, broad-spectrum oral antibiotic with minimal side effects and proven efficacy in multi-system bacterial infections.
Key Features
| Features | Description |
|---|---|
| Active Ingredient | Azithromycin 250 mg |
| Antibiotic Class | Macrolide |
| Spectrum of Activity | Broad-spectrum bacteriostatic against respiratory, dermatological, and urogenital infections |
| Pharmacokinetics | Rapid absorption; peak plasma concentration within 2-3 hours; long half-life (~68 hours) |
| Dosing Regimen | Once daily |
| Treatment Duration | Short course of 3 to 5 days depending on infection type and severity |
| Tissue Penetration | High intracellular accumulation and extensive tissue distribution targeting infection sites |
| Manufacturing Standards | GMP-compliant; formulated by Dr Precision |
| Applicable Patient Groups | Adults and pediatric patients (dosage adjusted accordingly) |
| Formulation | Oral tablet for systemic antibacterial therapy |
| Attributes | Description |
|---|---|
| Dosage Form | Tablet |
| Dosage Strength | 250 mg Azithromycin per tablet |
| Manufacturer | Dr Precision |
| Storage Conditions | Store in a cool, dry place away from direct sunlight |
| Package Types | Available in blister packs or bottles |
| Indications | Respiratory tract infections, skin and soft tissue infections, urogenital infections, ENT infections |
| Mechanism of Action | Binds 50S ribosomal subunit inhibiting bacterial protein synthesis |
| Post-antibiotic Effect | Prolonged antibacterial activity after plasma decline |
| Patient Compliance Feature | Once daily dosing with short treatment duration |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
AZITHRO-MAX 250 is rapidly absorbed and achieves peak plasma concentration within 2-3 hours, with extensive tissue penetration and a long half-life of about 68 hours. This allows once-daily dosing and a shorter treatment duration of 3 to 5 days, simplifying the regimen and improving patient compliance.
It is formulated for respiratory tract infections (e.g., pneumonia, sinusitis), skin and soft tissue infections (e.g., cellulitis, impetigo), and urogenital infections such as non-gonococcal urethritis and cervicitis caused by Chlamydia trachomatis.
Azithromycin has high intracellular accumulation particularly in phagocytic cells that transport the drug to infection areas, ensuring high tissue concentrations that persist even after plasma levels decrease, thus providing effective targeted antibacterial action.
Yes, AZITHRO-MAX 250 can be used in pediatric patients with appropriate dosage adjustments as per clinical guidelines for treating bacterial infections.
The tablet is manufactured under Dr Precision's GMP-compliant processes, ensuring high-quality formulation, safety, and efficacy standards.
Country Of Origin: India
AZITHRO-MAX 250 Tablet is a clinically trusted antibiotic containing Azithromycin 250 mg, formulated to combat a broad range of bacterial infections with precision and efficiency. It is widely prescribed for respiratory tract infections, skin infections, and sexually transmitted diseases. Manufactured to the highest global pharmaceutical standards, AZITHRO-MAX 250 ensures optimal bioavailability, minimal side effects, and a short treatment duration, making it a valuable solution for healthcare professionals and international pharmaceutical partners.
This product is manufactured under the Dr Precision label, ensuring GMP-compliant quality and precision formulation standards.
AZITHRO-MAX 250 Tablet is an oral antibiotic preparation containing 250 mg of Azithromycin, a macrolide class antimicrobial agent with broad-spectrum bacteriostatic activity. It is designed to treat a wide variety of bacterial infections, especially those involving the respiratory tract, skin and soft tissues, genitourinary system, and ear, nose, and throat (ENT). As a semi-synthetic derivative of erythromycin, Azithromycin functions by binding to the 50S ribosomal subunit of susceptible bacteria, thereby inhibiting protein synthesis and suppressing bacterial proliferation. This mechanism allows AZITHRO-MAX 250 to effectively stop the growth of infection-causing pathogens and restore patient health efficiently.
AZITHRO-MAX 250 is commonly prescribed in the treatment of acute bacterial exacerbations of chronic bronchitis, community-acquired pneumonia, sinusitis, pharyngitis, and tonsillitis. It is also an effective option in dermatological infections such as cellulitis, impetigo, folliculitis, and infected wounds. The medication is often utilized in urogenital infections including non-gonococcal urethritis and cervicitis caused by Chlamydia trachomatis. Due to its broad antibacterial coverage, AZITHRO-MAX 250 is suitable for both adults and pediatric patients when used in appropriate dosages.
One of the distinguishing features of AZITHRO-MAX 250 is its superior pharmacokinetic profile. It is rapidly absorbed from the gastrointestinal tract and achieves peak plasma concentrations within two to three hours post-administration. Azithromycin is characterized by extensive tissue distribution and high intracellular accumulation, particularly in phagocytic cells that transport the drug to infection sites. This targeted delivery ensures prolonged tissue concentrations even after plasma levels have declined, allowing for once-daily dosing and shorter treatment durations. This property is a significant advantage in enhancing patient adherence, especially in outpatient care.
A standard course of AZITHRO-MAX 250 may range from three to five days depending on the severity and type of infection. The reduced frequency of dosing and short duration of therapy compared to other antibiotics makes it a preferred option for patients and prescribers. Furthermore, Azithromycin has a long terminal half-life, typically around 68 hours, which supports its sustained activity and contributes to its post-antibiotic effect.
Inclusive of all taxes
You Save: 0
Surat , India
Manufacturer, Contractor, Retailer, Brand Owner, Distributor, Exporter, Importer, Wholesaler, Startup
GST- 24abdfb4194j1ze
